CASE DISCUSSION

Role of GLP 1 RA in Weight loss

Presented from India by Dr. Leena Mahana Kapoor

Likes

2201

Views

110

Bookmarks

Case Description

GLP-1 receptor agonists (GLP-1 RAs) play a significant role in weight loss by enhancing insulin secretion, inhibiting glucagon release, and slowing gastric emptying, which helps reduce appetite and food intake. These medications, originally developed for managing type 2 diabetes, have been shown to...

Case Summary

GLP-1 receptor agonists are novel drugs initially commissioned for type 2 diabetes but found to enable significant weight loss. These drugs work on the GLP receptor and are effective in helping patients lose weight, primarily through injectable forms, although an oral version is available. Beyond weight loss, they offer benefits in managing pre-diabetes and diabetes, neuroprotective effects, cardiovascular benefits, and improved metabolic health.

Speaker Profile

Dr. Leena Mahana Kapoor

Specialist Internal Medicine and Diabetologist, Aster DM Healthcare, Dubai

Disclosures

Assimilate requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships for anyone with the ability to control the content of this educational activity have been reviewed and mitigated. Others involved in the planning of this activity have no relevant financial relationships.